- #27 Pankaj Patel & family ₹91,800 Cr

About Cadila Laboratories Private Limited
Data last updated:
Cadila Laboratories Private Limited is a public limited company based in Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 June 1973 and has been in existence for over 53 years.
Its director Pankaj Patel and family are #27 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1973PLC002286. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.75 Cr. It is led by directors Pankaj Ramanbhai Patel and Sharvil Pankajbhai Patel.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ghodasar Maninagar Ahmedabad – 8, Gujarat, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.01 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹5.22 Cr (net margin 86.8%) and EBITDA of ₹5.95 Cr (EBITDA margin 99%).
Court records list 25 cases involving the company, including 10 filed by the company and 15 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zyduscadila.com.
Company details
Recognitions & Rankings of Cadila Laboratories
Contact details
Cadila Laboratories Private Limited's registered office is in Gujarat. Its website is zyduscadila.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGhodasar Maninagar Ahmedabad – 8, Gujarat, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Cadila Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cadila Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Cadila Laboratories Private Limited
FY 2025 filings availableCadila Laboratories Private Limited reported revenue of ₹6.01 Cr (up 2019% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.95 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.22 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 99% | ||||
| Net Profit Margin | 86.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cadila Laboratories Private Limited, buy the company report.
Board of directors of Cadila Laboratories Private Limited
Cadila Laboratories has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Ramanbhai Patel Also directs: Zandra Infrastructure LLP, Zydus Hospital LLP, Zandra Herbs and Plantations LLP and 5 more | Director | 09 Mar 1978 | 48 Years 8 Months | Current |
| Sharvil Pankajbhai Patel Also directs: Zandra Infrastructure LLP, Zydus Hospital LLP, Zandra Herbs and Plantations LLP and 5 more | Director | 19 Apr 2003 | 23 Years 6 Months | Current |
Auditor
Cadila Laboratories Private Limited is audited by Mukesh M. Shah & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mukesh M. Shah & Co. | FY 2023 | 106625W |
Shareholding
The shareholding of Cadila Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cadila Laboratories Private Limited, buy the company report.
Legal cases
Cadila Laboratories Private Limited has 25 court cases on record: 10 filed by Cadila Laboratories, 15 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 17 | 12 | 0 |
| District courts | 4 | 1 | 0 |
| Supreme Court | 4 | 2 | 0 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Appeal | Filed against the company by Indian Drugs & Pharmaceuticalsltd | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against St. Paul Mercury Insurance Co. | Disposed |
| Bombay High Court | Court case (CHS) | Filed by the company against St. Paul Mercuarry Insurance Co. and Cadila Healthcare Ltd. and Anr. | Disposed |
| High Court, GUJARAT | Court case (ITR) | Filed against the company by Commissioner of Income Tax | Disposed |
| Bombay High Court | Court case (CHS) | Filed by the company against St. Paul Mercury Insurance Company and Cadila Healthcare Ltd. and Anr. | Disposed |
To see the full case history of Cadila Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cadila Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cadila Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Cadila Laboratories Private Limited, buy the company report.
Recent activity
Cadila Laboratories Private Limited has 8 board changes on record since 1973: 5 appointments and 3 cessations. The latest: Rajiv Indravadan Modi ceased to be Director on 08 Mar 2024.
News
Frequently asked questions
Cadila Laboratories is an active public limited company based in Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 June 1973 (53+ years old) and is registered under CIN U24231GJ1973PLC002286.
Cadila Laboratories has 2 current directors:
- Pankaj Ramanbhai Patel - Director
- Sharvil Pankajbhai Patel - Director
The latest financial statements of Cadila Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
No. Cadila Laboratories has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Cadila Laboratories is U24231GJ1973PLC002286. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cadila Laboratories has 25 court cases on record: 10 filed by the company and 15 filed against it. Most are in the high courts.
Cadila Laboratories was incorporated on 15 June 1973, making it 53+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Rajiv Indravadan Modi ceased to be Director on 08 Mar 2024. Monika Garware ceased to be Director on 14 Nov 2018. Monika Garware was appointed as Director on 24 Dec 2012. Cadila Laboratories has 8 board changes on record in total.
Cadila Laboratories can be reached through the website zyduscadila.com. Its registered office is in Gujarat, India.
The registered office of Cadila Laboratories is at Ghodasar Maninagar Ahmedabad – 8, Gujarat, India.

